The weak market sentiments, especially in the wake of the Ukraine-Russia war, have been a dampener for the IPO.
Oxemia (Desidustat) is a breakthrough treatment for Anemia associated with Chronic Kidney Disease (CKD) in Patients either on Dialysis or Not on Dialysis.
Company stated that the total estimated Capital Expenditure for this new facility will be approximately Rs22 to Rs24 crore which shall be contributed through internal accruals.
Hindustan Copper and Vedanta were also in the fast lane amid raging copper and aluminium prices.
The bid project cost is Rs636.98 crore and the estimated completion period is 24 months.
This is a new rating from CRISIL Ratings Limited for the Bank’s infrastructure bonds, the company said.
The collaboration will offer more value to customers in the form of an enhanced rewards programme.
Record date for Distribution is 11 March 2022
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
